BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    MARATHON

    MDR report key: 22822396 · Received August 15, 2025

    Report

    Report Number
    2029214-2025-01834
    Event Type
    Malfunction
    Date Received
    August 15, 2025
    Date of Event
    May 26, 2025
    Report Date
    August 15, 2025
    Manufacturer
    MICRO THERAPEUTICS, INC. DBA EV3
    Product Code
    KRA
    UDI-DI
    00847536005914
    PMA / PMN Number
    K093750
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    CH
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    H3. PRODUCT ANALYSIS: ¿ EQUIPMENT USED: VIS (M-78210), 203CM RULER (M-83361) ¿ AS FOUND CONDITION: THE MARATHON CATHETER WAS RETURNED WITHIN A SHIPPING BOX AND A PLASTIC BIO-POUCH. THE MARATHON CATHETER WAS RETURNED SEPARATED INTO TWO SEGMENTS. ¿ VISUAL INSPECTION/DAMAGE LOCATION DETAILS: NO DAMAGE WAS FOUND WITH THE MARATHON CATHETER HUB. THE MARATHON CATHETER BODY WAS FOUND SEPARATED (CUT) AT ~6.1CM FROM THE PROXIMAL END OF THE CATHETER HUB. THE MARATHON CATHETER DISTAL SEGMENT WAS ALSO FOUND SEPARATED (CUT) ¿ TESTING/ANALYSIS: THE MARATHON CATHETER DISTAL SEGMENT TOTAL LENGTH WAS MEASURED TO BE ~134.5CM. WHEN COMPARED TO THE PRODUCT DRAWING, ~28.0CM TO ~33.0CM OF THE MARATHON CATHETER WAS NOT RETURNED. THE MARATHON CATHETER PROXIMAL SEGMENT WAS FLUSHED WITH WATER AND TESTED WITH AN IN-HOUSE X-PEDION-10 GUIDEWIRE (MODEL: 103-0605-200 LOT: 9579796). NO ISSUES WERE ENCOUNTERED DELIVERING THE IN-HOUSE X-PEDION-10 GUIDEWIRE THROUGH THE MARATHON CATHETER HUB. ¿ CONCLUSION: BASED ON THE DEVICE ANALYSIS AND REPORTED INFORMATION, THE CUSTOMER¿S ¿CATHETER RESISTANCE AT HUB¿ REPORT COULD NOT BE CONFIRMED. NO ISSUES WERE ENCOUNTERED DURING TESTING WITH AN IN-HOUSE GUIDEWIRE. THE GUIDEWIRE USED IN THE EVENT WAS NOT RETURNED. THEREFORE, AN ANALYSIS COULD NOT BE PERFORMED, AND ANY CONTRIBUTING FACTORS COULD NOT BE ASSESSED. THE CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. REGARDING THE OBSERVED CATHETER SEPARATION (CUT) ISSUE, AS THIS WAS NOT REPORTED BY THE CUSTOMER THE CAUSE COULD NOT BE DETERMINED. **THIS EVENT IS REPORTED AT THIS TIME BASED ON ANALYSIS FINDINGS DUE TO AN ABUNDANCE OF CAUTION ARE DETERMINED TO BE REPORTABLE. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

    Description of Event or Problem · 0

    MEDTRONIC RECEIVED INFORMATION REGARDING A MARATHON MICROCATHETER THAT HAD RESISTANCE WITH THE GUIDEWIRE AT THE HUB. THE PATIENT WAS UNDERGOING AN EMBOLIZATION PROCEDURE VIA FEMORAL ACCESS TO TREAT A RIGHT OPHTHALMIC ARTERY VESSEL MALFORMATION INVOLVING TWO VESSELS. VESSEL TORTUOSITY WAS MODERATE. IT WAS REPORTED THAT THE DEVICES WERE PREPARED AND CATHETER FLUSHED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). AN APOLLO CATHETER WAS USED TO EMBOLIZE THE FIRST INVOLVED VESSEL. A MARATHON CATHETER WAS THEN SELECTED FOR EMBOLIZATION OF THE SECOND VESSEL. DURING THE GUIDEWIRE PLACEMENT PROCESS, THE GUIDEWIRE COULD NOT ENTER THE MARATHON CATHETER LUMEN. AFTER MULTIPLE UNSUCCESSFUL ATTEMPTS, THE MARATHON WAS WITHDRAWN AND IT WAS FOUND THAT THE CONNECTIVE VALVE WAS LOOSE FROM THE CATHETER, RESULTING IN DISTANCE BETWEEN THE INTRODUCER SHEATH AND MARATHON CONNECTION CAUSING THE GUIDEWIRE TO BE UNABLE TO ENTER THE CATHETER LUMEN. IT WAS NOTED THAT THE POSTERIOR OPHTHALMIC ARTERY DEVELOPED SPASM AND STENOSIS SO THE PROCEDURE HAD TO BE TERMINATED THOUGH IT WAS NOTED THAT THERE WERE NO PATIENT SYMPTOMS OR COMPLICATIONS ASSOCIATED WITH THE DEVICE ISSUE. ADDITIONAL INFORMATION RECEIVED REPORTED THERE WAS NO SEPARATION OF THE HUB FROM THE CATHETER. THE VASOSPASM/STENOSIS WAS NOT RELATED TO THE CATHETER. UNABLE TO CONFIRM WHETHER VASOSPASM/STENOSIS WAS RELATED TO THE SURGERY. SUSPECTED PRIMARY SPASM. THE SURGERY WAS COMPLETED SUCCESSFULLY. THE GUIDEWIRE WAS NOT A MEDTRONIC DEVICE. THE PATIENT IS RECOVERING WITH SLIGHT IMPROVEMENT IN SYMPTOMS. ADDITIONAL INFORMATION WAS RECEIVED STATING THAT THE "CONNECTIVE VALVE" WAS REFERRING TO THE HUB. STENOSIS WAS NOT PRE-EXISTING; THERE WAS NO PREVIOUS SPASM OR STENOSIS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2457196 MARATHON CATHETER, CONTINUOUS FLUSH KRA MICRO THERAPEUTICS, INC. DBA EV3 105-5056 B743678 00847536005914

    Patients

    Seq Age Sex Outcome Treatment
    1 56 YR Male